MoneyWorks4Me

Bharat Immunologicals & Biological Corporation informs about board meeting

23 Jan 2020 Evaluate

Bharat Immunologicals & Biological Corporation has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 31st January 2020, to approve and take on record the Un-audited Quarterly Financial Results of the Company for the quarter ended 31st December 2019.

The above information is a part of company’s filings submitted to BSE.


Bharat Immunological Share Price

18.00 2.76 (18.11%)
10-Sep-2026 10:10 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1853.25
Dr. Reddys Labs. 1139.55
Cipla 1371.90
Lupin 2081.00
Zydus Lifesciences 1125.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: